fiacitabine has been researched along with B Virus Infection in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donner, AL; Leyland-Jones, B | 1 |
| Calnek, BW; Schat, KA; Schinazi, RF | 1 |
| de Clercq, E | 2 |
| Armstrong, D; Fox, JJ; Leyland-Jones, B; Lopez, C; Philips, FS; Schneider, R; Tan, CT; Watanabe, KA; Young, CW | 1 |
| Fanucchi, MP; Feinberg, A; Fox, JJ; Hancock, C; Leyland-Jones, B; Philips, FS; Vidal, PM; Watanabe, KA; Williams, L; Young, CW | 1 |
| Rollinson, EA | 1 |
2 review(s) available for fiacitabine and B Virus Infection
| Article | Year |
|---|---|
Nucleoside analogues as antiviral agents.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Chemical Phenomena; Chemistry; Cytarabine; Deoxyuridine; Guanine; Herpesviridae Infections; Humans; Idoxuridine; Nucleosides; Ribavirin; Thymidine; Virus Diseases; Viruses | 1981 |
Antiherpes drugs: promises and pitfalls.
Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cytarabine; Drug Resistance, Microbial; Herpesviridae Infections; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Vidarabine | 1984 |
5 other study(ies) available for fiacitabine and B Virus Infection
| Article | Year |
|---|---|
2'Fluoro-5-iodo-arabinosyl-cytosine: a new agent for herpes infections in the immunosuppressed patient.
Topics: Antiviral Agents; Bone Marrow; Bone Marrow Transplantation; Cytarabine; Drug Evaluation; Herpesviridae Infections; Humans; Immunosuppression Therapy; Kinetics | 1984 |
Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Cytarabine; Cytidine Deaminase; Herpesviridae Infections; Herpesvirus 2, Gallid; Marek Disease; Nucleoside Deaminases; Thymidine Kinase; Turkeys; Virus Replication | 1984 |
Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Topics: Antiviral Agents; Cytarabine; Drug Evaluation; Hematopoiesis; Herpesviridae Infections; Humans; Immunosuppression Therapy; Neoplasms | 1983 |
Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
Topics: Adult; Aged; Antiviral Agents; Biotransformation; Chromatography, High Pressure Liquid; Cytarabine; Female; Glucuronates; Herpesviridae Infections; Humans; Immune Tolerance; Kinetics; Male; Middle Aged; Plasma | 1985 |
Comparative efficacy of three 2'-fluoropyrimidine nucleosides and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW B759U) against pseudorabies and equine rhinopneumonitis virus infection in vitro and in laboratory animals.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cricetinae; Cytarabine; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Equid; Herpesvirus 1, Suid; Male; Mice; Pseudorabies; Pyrimidine Nucleosides | 1987 |